A comprehensive narrative review published in Frontiers in Adolescent Medicine challenges the initial promise of e-cigarettes as harm-reduction tools, presenting evidence that they have instead fueled a new nicotine epidemic among adolescents. Led by researchers from the University of Parma, the analysis synthesizes evidence through May 2025 on vaping's epidemiology, biological effects, and prevention strategies in youth. Epidemiological data from Italian adolescents aged 13 to 15 reveals a striking reversal: traditional cigarette smoking declined from 21 percent to 16 percent between 2010 and 2022, while approximately 20 percent reported regular e-cigarette use, with one-third having experimented with devices. E-cigarettes are now the most prevalent nicotine products among youth globally. Marketing strategies mirror historical tobacco industry tactics, emphasizing rebellion and sophistication through appealing flavors and sleek designs. Despite widespread misconceptions—up to 80 percent of adolescent users believe nicotine-containing products are nicotine-free—the biological evidence proves concerning. Vaping aerosols contain volatile organic compounds, aldehydes, and heavy metals that induce oxidative stress, inflammation, and cellular injury, causing systemic health effects extending well beyond pulmonary damage. This represents a critical public health challenge requiring enhanced enforcement of sales restrictions and prevention initiatives.

The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives announced on September 23 that it has joined the interagency Trade Fraud Task Force to combat illegal, misdeclared, and smuggled vape, nicotine, and tobacco products entering U.S. commerce. ATF's involvement leverages its statutory authority under the Prevent All Cigarette Trafficking Act, or PACT Act, to trace illicit products from U.S. entry points through domestic trafficking networks. Originally launched in August 2025 by the Department of Justice and Homeland Security Investigations, the task force targets false customs declarations, mislabeled shipments, and other import-evasion schemes. ATF's addition strengthens enforcement capabilities by bringing authority over interstate sales of tobacco products and electronic nicotine delivery systems, or ENDS, which Congress expanded under PACT Act coverage in 2021. The task force has already surpassed $1 billion in civil and criminal recoveries less than a year after launch. ATF's role focuses on tracing products across supply chains and enforcing registration, reporting, and compliance requirements among sellers, distributors, and delivery services.

Australia's Therapeutic Goods Administration has classified 6-methylnicotine (also known as Metatine or 6-MN), a nicotine analogue, as a prohibited substance under the Poisons Standard effective October 1, 2026. The substance has been identified in e-cigarettes and oral pouches marketed misleadingly as "nicotine-free" or "nicotine alternatives." The TGA determined that Schedule 9 classification—the strictest category—was warranted due to 6-methylnicotine's acute toxicity, high addiction potential, and evidence suggesting it has greater affinity for certain nicotinic receptors than nicotine, potentially causing more severe withdrawal symptoms and accelerated addiction development. Unstandardized dosages in illicit products pose additional risks of overdose and acute poisoning. The decision followed public consultation receiving 163 contributions and recommendations from the Drug Classification Advisory Committee. The TGA confirmed no therapeutic benefits exist for this substance and that no currently legal Australian products will be affected. This classification strengthens enforcement mechanisms and penalties across federal, state, and territorial legislation, protecting vulnerable populations from deceptive marketing practices.

The tobacco industry has historically manipulated nicotine's addictive properties and employed exploitative marketing to attract and retain customers. As societal preferences evolved, tobacco companies adapted by developing new products including chewing tobacco, cigarettes, electronic nicotine delivery systems (ENDS), and nicotine pouches. These companies leverage both traditional and social media, strategically targeting diverse populations through advertising campaigns that exploit gender roles, physician endorsements, glamour, youth culture, and health trends. Understanding these manipulative marketing techniques is critical for empowering youth to recognize predatory targeting and avoid nicotine addiction's substantial financial and health consequences. Historically, chewing tobacco dominated until the 1880s when James Bonsack's cigarette machine revolutionized production. Duke & Son's adoption of this technology dramatically increased cigarette manufacturing and consumption, spreading addiction across military and civilian populations. Examining past advertising strategies reveals how the tobacco industry continuously reinvents itself to exploit fundamental human experiences, making awareness essential for protecting vulnerable populations from contemporary nicotine marketing tactics.

A new vaping products duty has been implemented in the United Kingdom, charging £2.20 per 10ml of e-liquid regardless of nicotine content, payable by manufacturers, importers, and approved warehouse keepers. The tax aims to reduce vaping's appeal to young people and non-smokers while supporting public health objectives. Concurrently, HM Revenue and Customs has launched the Vaping Duty Stamps Scheme to enhance supply chain traceability and combat illicit trade, with a six-month grace period allowing retailers to clear existing stock before mandatory compliance on April 1. Tobacco duty has also increased by £2.20 per 100 cigarettes to maintain incentives for smokers to switch to vaping. New travellers' allowances permit individuals arriving in Great Britain to import up to 50ml of vaping liquid duty-free for personal consumption. Treasury officials emphasize these measures will support law enforcement against non-compliant retailers, while health authorities stress that although vaping is less harmful than smoking for adult cessation, children and non-smokers should not vape, positioning these measures as part of broader efforts to tackle youth vaping through reduced affordability and availability.

The Halo Smart Sensor is a comprehensive environmental monitoring device designed for privacy-sensitive areas, trusted by over 100,000 organizations globally. This all-in-one solution detects vaping and smoking while identifying attempts at sensor tampering or masking, simultaneously monitoring air quality through detection of specific contaminants including carbon dioxide, carbon monoxide, nitrogen dioxide, total volatile organic compounds, and ammonia. Beyond vape detection, the sensor tracks sound levels, occupancy rates, and security threats with real-time alerting capabilities. Operating within an optimal detection radius of eight to twelve feet, the device maintains effectiveness even when vape is deliberately obscured by clothing. The Halo Smart Sensor supports workplace compliance by providing analytics, reporting, and multi-site management features while preserving individual privacy through camera-free monitoring. School districts and other organizations have praised its cost-effectiveness and ease of implementation. The system enables efficient resource management and enhances overall health, safety, and environmental oversight across diverse institutional settings, making it particularly valuable for protecting vulnerable environments while maintaining security protocols.

E-cigarettes are becoming an increasingly serious threat to youth in South Korea, with products now disguised as watches, pens, and game consoles making detection difficult. According to Lee Sungkyu, director of the Korea Tobacco Control Research and Education Center, official youth smoking statistics report rates of three to four percent, yet nearly half of high school students admit to smoking when interviewed directly. The behavior differs markedly from traditional cigarettes; users continuously keep e-cigarettes in their mouths throughout the day, making consumption patterns difficult to monitor. Recent regulatory changes in April recognized synthetic nicotine as tobacco, yet enforcement remains inadequate as many unmanned vending machines lack proper age-verification systems and contain pre-amendment inventory. These modified products deliberately target adolescents and exploit regulatory loopholes, while the long-term health consequences remain unknown. Lee emphasized that outdated education and inadequate distribution management have created a vulnerable environment where teenagers can easily access these products, with the most pressing concern being unforeseen health impacts that may emerge decades later.

South Korea's vaping market has undergone significant structural changes following the April 24, 2026 expansion of the Tobacco Business Act, which brought synthetic nicotine products under tobacco regulatory frameworks for the first time. Customs data reveal that South Korea imported 12,126 kilograms of nicotine analogues—compounds chemically distinct from but structurally similar to nicotine—between April and August 2026, worth $463,422. This surge represents 73.2 percent of all nicotine-analogue imports since the Korea Customs Service began separately classifying these products in October 2025. Notably, synthetic-nicotine imports plummeted from a record 589,165 kilograms in March to just 8,919 kilograms by June, totaling 231,663 kilograms for the five-month period. Regulatory changes have also reshaped retail distribution, with monitoring of Seoul and Gyeonggi Province documenting fewer traditional vape stores, increased unmanned outlets, and expanded online sales. The shift reflects importers' apparent pivot toward nicotine analogues like 6-methylnicotine to circumvent newly applicable tobacco taxes and advertising restrictions, signaling how regulatory intervention immediately redirects market behavior toward potentially unregulated alternatives.

Jovan Zubović is an author contributing to Tobacco Induced Diseases, a peer-reviewed journal focused on tobacco-related health research. His published work includes studies examining heated tobacco products and smoking behaviors. In one research paper co-authored with Aleksandar Zdravković and Boban Nedeljković, published in 2026, the authors analyzed tax differentials, relative prices, and excise tax pass-through mechanisms for heated tobacco products in Serbia. Another study conducted with Zdravković and Olivera Jovanović investigated smoking patterns during the COVID-19 pandemic, using evidence from Serbia and published in 2022. The journal itself publishes comprehensive research including systematic reviews on emerging tobacco products such as IQOS and e-cigarettes, examining their health impacts across respiratory, oral, and cardiovascular domains. Featured studies also explore tobacco use prevalence among diverse populations including Malaysian adults and adolescents, alongside investigations into risk factors and associations between various tobacco products and health outcomes. This research contributes essential evidence for understanding contemporary tobacco product use patterns and their public health implications.

A recent investigation in Georgia highlights growing concerns about unregulated products sold at vape and smoke shops that may not be legal or safe despite their retail availability. On September 21, law enforcement executed eight search warrants at four vape stores in Blackshear, Jesup, and Ludowici, seizing illegal THC products including marijuana falsely labeled as hemp flower and banned THCA products. Georgia Agriculture Commissioner Tyler J. Harper emphasized the state's zero tolerance for illegal THC sales. The investigation coincides with renewed scrutiny of kratom, an herbal extract from a Southeast Asian tree sold widely at vape shops and gas stations. Two University of Mississippi students died in recent weeks with kratom packages found at both scenes, though toxicology reports remain pending and investigators have not confirmed kratom as the cause. While legal federally, kratom is banned or restricted in several states. University of Michigan and Texas State University researchers report kratom use is at an all-time high in the U.S., with over 5 million lifetime users including more than 100,000 children ages 12 to 17. Health officials warn that concentrated and chemically altered kratom products pose particular risks, as consumers cannot easily distinguish between safe and dangerous formulations.

South Korea's amended Tobacco Business Act, effective April 24, expanded tobacco regulations to include products containing natural or synthetic nicotine, successfully reducing synthetic nicotine imports by 97 percent. However, the law created significant regulatory gaps that vapers are exploiting. Nicotine analogues like 6-methylnicotine and nicotine-free e-liquids remain unregulated, escaping restrictions on promotions, online sales, taxation, and use in nonsmoking areas. Consequently, imports of nicotine-free e-cigarette liquid more than doubled, rising 105 percent to $9.21 million in the first eight months of 2024, while online listings for these products increased 86.3 percent. Critics, including Democratic Party Rep. Lee In-young and the Korea Center for Tobacco Control Research and Education, warn that the loophole enables aggressive marketing of fruit-flavored alternatives that deliver comparable effects to regulated products, potentially endangering teenagers' health. The government's regulatory oversight remains inadequate to address this evolving market shift toward uncontrolled nicotine substitutes.

A new study published in Toxicology Reports examined Nixodine-S, a formulated concentrate containing (S)-6-methylnicotine, as part of ongoing industry interest in replacing nicotine entirely. The research found that Nixodine-S did not induce cytotoxicity under test conditions where nicotine did, and it produced different activation patterns across nicotinic acetylcholine receptors. However, the study did not evaluate human subjects or measure effects on addiction, disease risk, or long-term health outcomes. The findings emerge as 6-methylnicotine products have already entered the market in e-cigarettes and oral pouches, with independent analyses revealing discrepancies between labeled and actual analogue content in U.S. products. The FDA has proposed seeking explicit congressional authority to regulate nicotine analogues. According to Rick Avila, CEO of Bonguard Naturals and co-author of the study, critical evidence remains absent to validate nicotine analogues as genuine substitutes, including human pharmacokinetic and abuse-liability studies. Nixodine-S, designed as a volume-for-volume nicotine substitute for vape and oral product manufacturing, represents a shift from traditional innovation focused on delivery mechanisms toward changing the pharmacologically active molecule itself.

South Korea's Ministry of Gender Equality and Family announced legislation to close a significant regulatory loophole affecting minors' access to e-cigarettes at unmanned stores. The pre-announced rule, with a notice period extending until October 6, will require unmanned e-cigarette retailers—businesses operating without staff or owners present—to implement age verification measures and display warning signage prohibiting minors from entering or working at these locations. This regulatory gap emerged after South Korea's April 2024 revision to the Tobacco Business Act formally classified e-cigarettes as tobacco products, extending restrictions to schools, hospitals, and designated outdoor no-smoking zones while banning online sales and promotional activities targeting youth. However, unmanned stores continued operating as enforcement points, enabling minors to purchase products unchecked. The initiative aligns with global efforts to strengthen tobacco regulations, following similar measures in the United Kingdom and the Maldives. The new legislation matters significantly for youth public health, as it addresses a critical enforcement gap in an otherwise comprehensive regulatory framework designed to protect minors from nicotine addiction.

South Korea's Ministry of Gender Equality and Family announced plans to extend vape regulations to unmanned e-cigarette stores, designating them as spaces where minors are prohibited from entering or working. The proposed administrative notice is open for public comment from September 14 through October 6. This measure targets automated retail locations without permanent staff, requiring operators to implement age-verification mechanisms at store entrances and display notices restricting minors. Under South Korea's existing Youth Protection Act, sellers must verify customer age at the point of sale, but the new proposal shifts compliance responsibility to the store-access level. Government officials cited the lack of sales staff at unmanned vape retailers as creating enforcement challenges for real-time purchase prevention. This initiative follows the April 2026 amendment to the Tobacco Business Act, which expanded tobacco definitions to include synthetic-nicotine vaping products previously unregulated. The regulatory expansion addresses a regulatory gap that had allowed synthetic-nicotine e-cigarettes to circumvent traditional tobacco restrictions. These measures represent South Korea's comprehensive effort to reduce youth access to vaping products across all retail channels.

Governments worldwide are increasingly adopting progressive regulatory frameworks for smokeless tobacco and nicotine products—including vapor, tobacco heating, herbal heating, and nicotine pouches—recognizing their potential to reduce smoking-related health impacts. Evidence from Sweden, the UK, New Zealand, and Canada demonstrates that regulated access to smokeless alternatives correlates with accelerated declines in smoking rates. Sweden exemplifies this success, approaching smoke-free status with approximately five percent smoking prevalence, substantially ahead of the EU's 2040 target. The article advocates for science-based, proportionate regulation that establishes robust product quality and safety standards while enabling adult access to satisfying nicotine products and age-appropriate flavors. Effective regulatory regimes should facilitate consumer information accessibility, prevent underage use through enforcement mechanisms, and encourage environmental responsibility. Achieving tobacco harm reduction requires coordinated efforts among governments, industry stakeholders, and public health communities to maximize smokeless products' contribution to reducing cigarette consumption and associated health burdens.

# Professional Summary The nicotine marketplace has undergone significant transformation, extending beyond traditional combustible cigarettes to encompass electronic nicotine delivery systems (ENDS), heated tobacco products (HTPs), nicotine pouches, and licensed medicinal nicotine products. This expansion has fundamentally altered exposure patterns, dependence mechanisms, and cessation outcomes, creating complexity in defining what "quitting" means in clinical and public health contexts. Researchers from Roswell Park Comprehensive Cancer Center, NHS Surrey, and Charité Universitätsmedizin Berlin conducted a comprehensive narrative review synthesizing evidence from neurobiology, epidemiology, clinical research, and population-level data to examine nicotine dependence across product categories. The analysis reveals that nicotine dependence results from interactions between pharmacological factors, delivery kinetics, behavioral conditioning, and deliberate product design features. While complete switching from combustible cigarettes to non-combustible alternatives may reduce exposure to smoking-related toxicants, these products frequently sustain nicotine dependence, facilitate dual use, and create new initiation pathways among previously nicotine-free individuals. Current cessation frameworks inadequately distinguish between smoking abstinence and complete nicotine cessation, particularly for long-term users of alternative products. The researchers advocate redefining optimal cessation endpoints to embrace "Total Quit"—complete freedom from nicotine dependence—and recommend tailored support addressing all nicotine product types.

Nicotine analogs are chemical compounds with structures similar to but distinct from nicotine, such as 6-methyl nicotine, which bind to nicotinic receptors in the brain. These compounds are marketed under trademarked names including Metatine, Imotine, Nixodine, NoNic6, and Ceretine. Despite minor chemical differences, these distinctions allow products to circumvent federal, state, and local regulations designed to prevent addiction and protect young people. Tobacco industry interest in nicotine analogs dates to the 1970s, when Philip Morris established the Nicotine Analog Program and R.J. Reynolds later launched the Committee on Nicotine Analog Research, motivated by potential regulatory evasion and product appeal enhancement. Currently, the FDA does not regulate nicotine analog products as tobacco or drugs, creating significant regulatory gaps. Products like Spree Bar, containing 6-methyl nicotine, claim exemption from pre-market authorization requirements while employing youth-targeted marketing through convenience stores and web channels using AI-generated characters. Some jurisdictions, including California and Denver, have begun addressing this loophole through regulatory action.

Liquid e-cigarettes marketed as "nicotine-free" are gaining popularity among teenagers despite misleading safety claims. A South Korean Ministry of Food and Drug Safety investigation of 105 online products revealed nicotine in 13 samples and a novel nicotine analog called 6-methylnicotine in 12 products. While nicotine analogs have slightly different molecular structures from traditional nicotine, they activate the same nicotinic acetylcholine receptors in the brain and produce similar addictive effects. The critical concern is that these compounds lack sufficient safety verification and clinical data, creating risks of unexpected acute toxicity. Professor Choi Sujeong from Gachon University warns that manufacturers exploit regulatory loopholes by claiming 6-methylnicotine doesn't legally qualify as nicotine. Adolescents face particular vulnerability since their brains develop until the mid-20s; nicotine exposure impairs frontal lobe functions including concentration, memory, planning, and impulse control. This deceptive marketing targeting teenagers poses significant neurological and cardiovascular risks despite product claims of harm reduction or smoking cessation benefits.

A comprehensive systematic review and meta-analysis examining the relationship between e-cigarette use and sleep health found that users experience 38% higher odds of sleep-related problems compared to never users. The analysis synthesized data from 16 cross-sectional studies encompassing over 150,000 participants, focusing exclusively on e-cigarette users to isolate the independent effects of vaping on sleep quality. The research identified nicotine's stimulant properties as a primary mechanism underlying sleep disruption, as the substance affects the central nervous system and impairs both sleep initiation and maintenance. Notably, the study found comparable adverse effects across both adolescent and adult populations, though adolescents may be particularly vulnerable due to their developing neurobiological systems and heightened sensitivity to nicotine exposure. Additional psychosocial stressors including academic pressure and peer influences may compound sleep disturbances in younger users. These findings contribute significantly to existing literature on substance use and sleep patterns, placing e-cigarettes alongside alcohol, marijuana, and cigarettes as agents that substantially compromise sleep health across age groups.

Audu's story exemplifies the growing threat of nicotine addiction in Nigeria, where at age twenty-one, early tobacco use triggered respiratory diseases and derailed his education. Dr Pavel Ursu of the WHO cited this case to illustrate tobacco's devastating impact on young lives. However, Nigeria's nicotine market is undergoing significant transformation beyond traditional cigarettes. The tobacco industry now markets alternative nicotine delivery systems including vapes, heated tobacco products, and nicotine pouches—products designed to appear technological, lifestyle-oriented, and crucially, positioned as harm reduction solutions. These products, available in various flavours and discreet formats, are increasingly visible in Nigerian retail environments, with investigations by The Colonist Report Africa documenting disposable vapes containing two to five percent nicotine in Port Harcourt markets and supermarkets in 2024. The industry's strategic shift toward harm reduction messaging raises critical concerns about commercial motivations disguised as public health solutions. This evolving landscape contextualizes the controversy surrounding the proposed amendment to Nigeria's National Tobacco Control Act, which extends beyond legislative disagreement to represent a fundamental struggle over how the tobacco industry adapts its communication strategies, diversifies product offerings, and builds political alliances in developing markets.